First Clinical Cases With PTA Dilatation Catheter Successfully Completed


December 10, 2007

December 10, 2007 – Ymed Inc. announced that it has successfully completed its first U.S. cases with its proprietary VascuTraK PTA Dilatation Catheter, a unique 5F compatible, single operator rapid exchange system.
YMed's VascuTraK II catheter is designed and indicated for vascular intervention of a wide range of peripheral arteries including the treatment of obstructive lesions of native or synthetic arteriovenous dialysis fistulae.
"The VascuTraK II catheter is an important advancement in technology for the treatment of patients with peripheral vascular disease (PVD), especially below the knee where amputation risks are the greatest," said Dr. Rajesh Dave, Chairman, Endovascular Medicine, Harrisburg Hospital, Harrisburg, PA.
Dr. Dave performed the initial clinical cases with commercially available VascuTraK II catheters. He noted that in some lesion subsets, including calcified lesions involving the popliteal artery, the VascuTraK II catheter was sufficient to complete the intervention without adjunctive devices that may increase restenois or require further intervention.
Balloon diameters range from 2.0 mm to 4.0 mm in 0.5 mm increments with balloon lengths of 20 mm to 120 mm. YMed plans to initiate U.S. Sales with a broad range of VascuTraK II PTA dilatation catheters during Q1 2008.
For more information: